Neuromedin N

Name: Neuromedin N | 92169-45-4
Brand: US-CATO
SKU: S57CPTD786431_10_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57CPTD786431_10_MG

Vendor: US-CATO

Product Information

Product Name

Neuromedin N

Brand Name

US-CATO

Product Number

CPTD786431

CAS

92169-45-4

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

9940301

IUPAC Name

(2S)-2-(2S,3S)-2-(2S)-2-(2S)-1-(2S,3S)-2-(2S)-2,6-diaminohexanoylamino-3-methylpentanoylpyrrolidine-2-carbonylamino-3-(4-hydroxyphenyl)propanoylamino-3-methylpentanoylamino-4-methylpentanoic acid

InChI Key

RZMLVIHXZGQADB-YLUGYNJDSA-N

SMILES

CCC@H(C)C@@H(C(=O)NC@@H(CC(C)C)C(=O)O)NC(=O)C@H(CC1=CC=C(C=C1)O)NC(=O)C@@H2CCCN2C(=O)C@H(C@@H(C)CC)NC(=O)C@H(CCCCN)N

References

Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid Targets

Publication Name: Molecules (Basel, Switzerland)

Publication Date: 2024-03-20

DOI: 10.3390/molecules29061390

Pro-neurotensin/Neuromedin N and Hypertension Risk: A Prospective Study

Publication Name: American Journal of Hypertension

Publication Date: 2021-10-16

DOI: 10.1093/ajh/hpab166

Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort

Publication Name: The Journal of clinical endocrinology and metabolism

Publication Date: 2021-05-20

DOI: 10.1210/clinem/dgab355

Pro-Neurotensin/Neuromedin N and Risk of Cognitive Impairment in a Prospective Study

Publication Name: Journal of Alzheimer's disease : JAD

Publication Date: 2020-08-18

DOI: 10.3233/jad-200456

Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours

Publication Name: Molecules (Basel, Switzerland)

Publication Date: 2020-07-24

DOI: 10.3390/molecules25153363

Neuromedin N

Product Information

General Information

References

Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid Targets

Pro-neurotensin/Neuromedin N and Hypertension Risk: A Prospective Study

Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort

Pro-Neurotensin/Neuromedin N and Risk of Cognitive Impairment in a Prospective Study

Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours

Neuromedin N

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Neuromedin N

Product Information

General Information

References

Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid Targets

Pro-neurotensin/Neuromedin N and Hypertension Risk: A Prospective Study

Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort

Pro-Neurotensin/Neuromedin N and Risk of Cognitive Impairment in a Prospective Study

Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours

Neuromedin N

Related Product

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

#title#

Login

Register